Articles by Christina I. Ortiz - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Christina I. Ortiz

Global Healthcare on the Ground: BIO and BIO Ventures for Global Health

A Focus on Creative Strategies to Help the Developing World.
Jun 2, 2011

A Focus on Creative Strategies to Help the Developing World.

Global Healthcare on the Ground: Roche Takes on Illnesses in LDCs

Efforts are made to educate health workers in less developed countries.
May 2, 2011

Efforts are made to educate health workers in less developed countries.

FDA Releases Strategic Priorities for 2011-2015

Apr 28, 2011

FDA has released a list of its strategic priorities for the next five years to address new global challenges.

USP Drug Quality Pilot Program Underway in Sub-Saharan Africa

Apr 21, 2011

On Apr. 18, 2011, scientists from the national laboratories of five African nations gathered in Accra, Ghana, to take part in a week of technical training put on by the US Pharmacopeia (USP) that will teach them how to detect substandard and counterfeit medicines.

Global Healthcare on the Ground: Framework Set for Supply-Chain Improvement

PRTM helps to improve supply-chain management and logistics in developing countries.
Apr 2, 2011

PRTM helps to improve supply-chain management and logistics in developing countries.

Global Healthcare on the Ground: FDA Tackles Rare Diseases

FDA's efforts to improve access to treatments for rare diseases.
Mar 2, 2011

FDA's efforts to improve access to treatments for rare diseases.

EMA Releases New Guidance on Stem Cell Products

Feb 10, 2011

On Feb. 4, 2011, the European Medicines Agency released new document on drug products that are manufactured using stem cells.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
29%
Oversee medical treatment of patients in the US.
11%
Provide treatment for patients globally.
7%
All of the above.
46%
No government involvement in patient treatment or drug development.
7%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here